GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medipharco Pharmaceutical JSC (HSTC:MTP) » Definitions » Debt-to-Revenue

Medipharco Pharmaceutical JSC (HSTC:MTP) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2010. Start your Free Trial

What is Medipharco Pharmaceutical JSC Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Medipharco Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Medipharco Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Medipharco Pharmaceutical JSC's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.


Medipharco Pharmaceutical JSC Debt-to-Revenue Historical Data

The historical data trend for Medipharco Pharmaceutical JSC's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipharco Pharmaceutical JSC Debt-to-Revenue Chart

Medipharco Pharmaceutical JSC Annual Data
Trend
Debt-to-Revenue

Medipharco Pharmaceutical JSC Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Medipharco Pharmaceutical JSC's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Medipharco Pharmaceutical JSC's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipharco Pharmaceutical JSC's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medipharco Pharmaceutical JSC's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medipharco Pharmaceutical JSC's Debt-to-Revenue falls into.



Medipharco Pharmaceutical JSC Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Medipharco Pharmaceutical JSC's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Medipharco Pharmaceutical JSC's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Medipharco Pharmaceutical JSC Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medipharco Pharmaceutical JSC's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipharco Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
08 Nguyen Truong to Street, Phuoc Vinh Ward, Thien Hue Province, Hue, VNM
Medipharco Pharmaceutical JSC is engaged in manufacturing, trading, and import-export medicines, medical equipment, and supplies, cosmetic products, sanitary products, biological products, essential oils, aromatherapy. Its products consist of Betamethason, Gentameson, Neutasol, Mediclovir, Rhumenol flu 500, and Clotrimazol among others.

Medipharco Pharmaceutical JSC Headlines

No Headlines